Veracyte
Develops molecular tests that guide cancer diagnosis, treatment, and recurrence monitoring.
$44.20
After-hours close+0.87 (+2.01%)
At close$43.33(−4.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.43 | — | — |
| Jul 2026 | $0.41 | $0.54 | +31.6% |
| May 2026 | $0.34 | $0.52 | +52.9% |
| Feb 2026 | $0.41 | $0.53 | +29.8% |
| Nov 2025 | $0.32 | $0.51 | +59.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | $0.43 | — | — | $147.1M | — | — |
| Jul 30, 2026 | $0.41 | $0.54 | +31.6% | $144.6M | $150.3M | +4.0% |
| May 5, 2026 | $0.34 | $0.52 | +52.9% | $130.4M | $139.1M | +6.7% |
| Feb 25, 2026 | $0.41 | $0.53 | +29.8% | $135.8M | $140.6M | +3.6% |
| Nov 4, 2025 | $0.32 | $0.51 | +59.4% | $135.8M | $131.9M | −2.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 24, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 4, 2023 | ||||||
| Feb 22, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 2, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Jul 29, 2021 | ||||||
| May 10, 2021 | ||||||
| Feb 17, 2021 | ||||||
| Nov 2, 2020 | ||||||
| Jul 30, 2020 | ||||||
| May 6, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Oct 22, 2019 | ||||||
| Jul 30, 2019 | ||||||
| Apr 30, 2019 | ||||||
| Feb 25, 2019 | ||||||
| Oct 29, 2018 | ||||||
| Jul 23, 2018 | ||||||
| May 1, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 6, 2017 | ||||||
| Jul 31, 2017 | ||||||
| May 3, 2017 | ||||||
| Mar 1, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 5, 2016 | ||||||
| Mar 10, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 13, 2015 | ||||||